Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2088788 | 1.00 | MAOA (0.43) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL29957421 | 0.85 | KDM1A (0.42) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL5782002 | 0.85 | KDM1A (0.42) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL19058720 | 0.78 | PTGS2 (0.41) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL2744266 | 0.78 | MAOA (0.39) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL7179132 | 0.76 | MGLL (0.42) | CA1CA2 | |
| SCHEMBL19341554 | 0.75 | MAOA (0.41) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL12215517 | 0.72 | MTNR1A (0.44) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL275380 | 0.70 | MAOA (0.47) | MAOAMAOBCYP11B2PTGS2CYP11B1 | |
| SCHEMBL4459793 | 0.70 | TRPA1 (0.43) | MAOAMAOBCYP11B2PTGS2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326776-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2025-10-23 | — | — | US | disclosed |
| US-20250257084-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2025-08-14 | — | — | US | disclosed |
| US-12275751-B2 | Organometallic complex, olefin polymerization catalyst system and polymerization process | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2025-04-15 | — | — | US | disclosed |
| EP-4496798-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | Nova Chemicals (International) S.A. (CH) | 2025-01-29 | — | — | EP | disclosed |
| CN-118900842-A | Organometallic complexes, olefin polymerization catalyst systems and polymerization processes | 诺瓦化学品(国际)股份有限公司 | 2024-11-05 | — | — | CN | disclosed |
| US-20240294560-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2024-09-05 | — | — | US | disclosed |
| US-11999763-B2 | Organometallic complex, olefin polymerization catalyst system and polymerization process | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2024-06-04 | — | — | US | disclosed |
| US-20240124502-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2024-04-18 | — | — | US | disclosed |
| WO-2023187552-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | NOVA CHEMICALS (INTERNATIONAL) S.A. (CH) | 2023-10-05 | — | — | WO | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-3027631-B1 | PROCESS FOR THE PREPARATION OF BRIDGED METALLOCENE COMPLEXES SUITABLE FOR USE IN OLEFIN POLYMERIZATION | SAUDI BASIC IND CORP (SA) | 2022-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124502-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | CYC1, CYP4F12, COASY | MAOA 1249/4885MAOB 1025/4885CYP11B2 269/4885 |
| US-12275751-B2 | Organometallic complex, olefin polymerization catalyst system and polymerization process | CYC1, CYP4F12, COASY | MAOA 1249/4885MAOB 1025/4885CYP11B2 269/4885 |
| US-20250257084-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | CYC1, CYP4F12, COASY | MAOA 1249/4885MAOB 1025/4885CYP11B2 269/4885 |
| US-20240294560-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | CYC1, CYP4F12, COASY | MAOA 1249/4885MAOB 1025/4885CYP11B2 269/4885 |
| US-20250326776-A1 | ORGANOMETALLIC COMPLEX, OLEFIN POLYMERIZATION CATALYST SYSTEM AND POLYMERIZATION PROCESS | LIG1, C1S, ALOX12 | MAOA 731/4885MAOB 534/4885CYP11B2 408/4885 |
| US-11999763-B2 | Organometallic complex, olefin polymerization catalyst system and polymerization process | CYC1, CYP4F12, COASY | MAOA 1249/4885MAOB 1025/4885CYP11B2 269/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.